https://biotechmorning.com/news/ipsen-albireo-liver-disease-candidates-terminated Biotech Morning en 2026-05-07T14:14:17.391Z Ipsen Spent $952M on a Company. Two of Its Drugs Just Hit the Trash. https://biotechmorning.com/news/sanofi-fda-voucher-program-withdrawal Biotech Morning en 2026-05-07T14:13:38.958Z Sanofi Just Broke Up With the FDA's Fastest Review Program https://biotechmorning.com/news/one-bad-day-killed-this-70m-biotech Biotech Morning en 2026-05-07T14:13:02.965Z One Bad Day Killed This $70M Biotech https://biotechmorning.com/news/avalo-phase-2-hs-results-abbvie-competition Biotech Morning en 2026-05-07T14:12:24.068Z The Tiny Biotech That Just Embarrassed AbbVie's Dermatology Team https://biotechmorning.com/news/fda-blinked-rare-cancer-drug-reversal Biotech Morning en 2026-05-07T14:11:39.587Z The FDA Just Blinked on a Rare Cancer Drug It Already Killed https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion-2 Biotech Morning en 2026-05-07T14:11:00.411Z UCB Just Dropped $2.2 Billion on a Company That Didn't Exist Two Years Ago https://biotechmorning.com/news/fda-real-time-clinical-trial-data-pilot Biotech Morning en 2026-05-07T14:10:17.199Z The FDA Just Killed the 60-Year-Old Way We Run Clinical Trials https://biotechmorning.com/news/primate-act-ban-monkey-imports-drug-development Biotech Morning en 2026-05-07T14:09:42.474Z Congress Wants to Ban Monkey Imports. Drug Developers Are Nervous. https://biotechmorning.com/news/cytospire-83m-gamma-delta-t-cell-engager Biotech Morning en 2026-05-07T14:09:01.492Z The $83M Bet on Your Body's Forgotten Immune Cells https://biotechmorning.com/news/china-supply-chain-regulations-biopharma-threat Biotech Morning en 2026-05-06T14:16:46.050Z China Just Made It Illegal to Leave Its Drug Supply Chain https://biotechmorning.com/news/bayer-perfuse-acquisition-ophthalmology-implant Biotech Morning en 2026-05-06T14:16:06.748Z Bayer Just Bet $2.45 Billion on an Eye Implant Most People Haven't Heard Of https://biotechmorning.com/news/cellcentric-220m-epigenetics-multiple-myeloma Biotech Morning en 2026-05-06T14:15:20.346Z The $220M Bet on an Epigenetic Light Switch for Blood Cancer https://biotechmorning.com/news/novo-nordisk-cagrisema-device-decision Biotech Morning en 2026-05-06T14:14:36.934Z Novo Nordisk Just Killed Part of Its Biggest Obesity Drug. Here's Why That's Good News. https://biotechmorning.com/news/biontech-restructuring-1860-jobs-oncology-pivot Biotech Morning en 2026-05-06T14:13:58.109Z BioNTech Built a Vaccine Empire. Now It's Tearing It Down. https://biotechmorning.com/news/gsk-siranbio-obesity-oligonucleotide-deal Biotech Morning en 2026-05-06T14:13:15.472Z GSK Just Paid $55M for a Drug That Melts Fat (Not Muscle) https://biotechmorning.com/news/madrigal-billion-dollar-bet-silencing-genes Biotech Morning en 2026-05-06T14:12:31.435Z Madrigal's Billion-Dollar Bet on Silencing Genes https://biotechmorning.com/news/fda-real-time-clinical-trial-data-sharing-pilot Biotech Morning en 2026-05-06T14:11:51.176Z The FDA Just Blew Up 60 Years of Clinical Trial Protocol